Achaogen (AKAO) Misses Q4 EPS by 26c

Achaogen (NASDAQ: AKAO) reported Q4 EPS of ($1.01), $0.26 worse than the analyst estimate of ($0.75). Revenue for the quarter came in at $2.03 million versus the consensus estimate of $2.85 million.

For earnings history and earnings-related data on Achaogen (AKAO) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
• Cheetah Net Supply Chain Service Inc. (CTNT) Reports Q2 EPS of $0.04